Inventor · disambiguated record
Roland Beckmann
Also filed as: BECKMANN ROLAND
23 granted patents·16 pending applications·113 citations·filing 2002–2024
94Inventor score
Top patents by PatentIndex Score
39 records- 0194US8470979B2Humanized antibody molecules specific for IL-31BONDENSGAARD KENT·Filed 2008·Granted Jun 25, 2013·40 cites·40 claims
- 0292US7696320B2Ligands that have binding specificity for VEGF and/or EGFR and methods of use thereforDOMANTIS LTD·Filed 2006·Granted Apr 13, 2010·25 cites·65 claims
- 0390US9708388B2Antibody light chainsDUTALYS GMBH·Filed 2013·Granted Jul 18, 2017·12 cites·15 claims
- 0488US9416184B2Method of treating pruritus with IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2015·Granted Aug 16, 2016·5 cites·28 claims
- 0588US8685669B2Nucleic acid molecules encoding humanized antibody molecules specific for IL-31ZYMOGENETICS INC·Filed 2013·Granted Apr 1, 2014·7 cites·15 claims
- 0685US9005921B2Polynucleotides encoding IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2014·Granted Apr 14, 2015·5 cites·30 claims
- 0783US7785453B2Electrode for electrolytic cellUHDENORA SPA·Filed 2006·Granted Aug 31, 2010·6 cites·14 claims
- 0881US2023279155A1Dual targetingHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0979US9982044B2Method of treating pruritus with IL-31 monoclonal antibody formulationsZYMOGENETICS INC·Filed 2017·Granted May 29, 2018·1 cites·24 claims
- 1079US2024101657A1Antibody that binds to vegf and il-1beta and methods of useHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1177US9738715B2IL-31 monoclonal antibody formulationsZYMOGENETICS INC·Filed 2016·Granted Aug 22, 2017·1 cites·8 claims
- 1275US9944719B2Dual targetingDUTALYS GMBH·Filed 2013·Granted Apr 17, 2018·2 cites·4 claims
- 1373US11866490B2Antibody that binds to VEGF and IL-1beta and methods of useHOFFMANN LA ROCHE·Filed 2021·Granted Jan 9, 2024·0 cites·36 claims
- 1473US11542327B2Methods of treating pruritic disease with IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2020·Granted Jan 3, 2023·0 cites·28 claims
- 1573US7780822B2Electrolytic cell with segmented and monolithic electrode designUHDENORA SPA·Filed 2006·Granted Aug 24, 2010·2 cites·7 claims
- 1671US11130804B2Antibody that binds to VEGF and IL-1beta and methods of useHOFFMANN LA ROCHE·Filed 2019·Granted Sep 28, 2021·0 cites·28 claims
- 1770US10640559B2Nucleic acid molecules encoding humanized IL-31 monoclonal antibodiesZYMOGENETICS INC·Filed 2018·Granted May 5, 2020·0 cites·10 claims
- 1868US2021079119A1Dual targetingHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1967US11732036B2Antibody that binds to VEGF-A and ANG2 and methods of useHOFFMANN LA ROCHE·Filed 2021·Granted Aug 22, 2023·0 cites·9 claims
- 2066US2025163139A1Antibody that binds to vegf-a and il6 and methods of useHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 2161US2018094078A1Dual targetingHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 2260US2023131782A1Ada-response specification assayHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2359US10738103B2Antibody light chainsHOFFMANN LA ROCHE·Filed 2017·Granted Aug 11, 2020·0 cites·7 claims
- 2458US2023105324A1Antibody that binds to vegf and pdgf-b and methods of useHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2556US2009081233A1Ligands that have binding specificity for VEGF and/or EGFR and methods of use thereforDOMANTIS LTD·Filed 2008·Application pending·0 cites
- 2655US8545844B2Humanized antibodies against human IL-22RABECKMANN ROLAND·Filed 2010·Granted Oct 1, 2013·1 cites·19 claims
- 2755US2014206846A1Dual TargetingBECKMANN ROLAND·Filed 2012·Application pending·0 cites
- 2853US2010056439A1Ligands that have binding specificity for egfr and/or vegf and methods of use thereforDOMANTIS LTD·Filed 2006·Application pending·0 cites
- 2952US7351317B2Electrolytic cell comprising an interior troughUHDENORA TECHNOLOGIES SRL·Filed 2003·Granted Apr 1, 2008·2 cites·10 claims
- 3051US7226885B2Method for producing gas diffusion electrodesGASKATEL GMBH·Filed 2002·Granted Jun 5, 2007·4 cites·12 claims
- 3151US2014255405A1Removal of Monomeric TargetsDUTALYS·Filed 2012·Application pending·0 cites
- 3251US2017253672A1Removal of monomeric targetsHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 3351US2010047171A1Fusion Proteins That Contain Natural JunctionsBECKMANN ROLAND·Filed 2007·Application pending·0 cites
- 3449US7938938B2Electrolysis cellUHDENORA SPA·Filed 2005·Granted May 10, 2011·0 cites·9 claims
- 3549US7901548B2Electrolysis cell with enlarged active membrane surfaceUHDENORA SPA·Filed 2006·Granted Mar 8, 2011·0 cites·11 claims
- 3647US2013041136A1Ligands that have binding specificity for egfr and/or vegf and methods of use thereforDOMANTIS LTD·Filed 2012·Application pending·0 cites
- 3745US2008292944A1Silver Gas Diffusion Electrode for Use in Air Containing Co2, and Method for the Production ThereofUHDE GMBH·Filed 2005·Application pending·0 cites
- 3841US8057713B2Method for the production of nickel oxide surfaces having increase conductivityBECKMANN ROLAND·Filed 2005·Granted Nov 15, 2011·0 cites·4 claims
- 3938US2014213459A1Antibodies with improved folding stabilityBECKMANN ROLAND·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Roland Beckmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →